JENNIFER BAILEY: Open Payments
NPI 1114705829 · ST. PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,064 in 348 payments from 14 companies in 2025. Trend: 2023 $54 · 2024 $1,878 · 2025 $4,064
Food & beverage: $3,952Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 122 | $876 |
| Teva Pharmaceuticals USA, Inc. | 86 | $668 |
| ABBVIE INC. | 25 | $413 |
| Alkermes, Inc. | 20 | $406 |
| E.R. Squibb & Sons, L.L.C. | 23 | $386 |
| Janssen Pharmaceuticals, Inc | 16 | $316 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $299 |
| Otsuka America Pharmaceutical, Inc. | 15 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $184 |
| Luye Pharma (USA) Ltd. | 5 | $131 |
Products named: INGREZZA, VRAYLAR, COBENFY, AUSTEDO XR, ARISTADA, INVEGA, CAPLYTA, UZEDY.
Industry payments across FL — which companies pay providers there.
